These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21052972)

  • 1. [Abrupt switch from extended-release oxcarbazepine to eslicarbazepine acetate].
    Steinhoff BJ; Trinka E; Wendling AS
    Nervenarzt; 2011 Jun; 82(6):764-7. PubMed ID: 21052972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overnight switching from oxcarbazepine to eslicarbazepine acetate: an observational study.
    Schmid E; Kuchukhidze G; Kirschner M; Leitinger M; Höfler J; Rohracher A; Kalss G; Wendling AS; Steinhoff BJ; Trinka E
    Acta Neurol Scand; 2017 Apr; 135(4):449-453. PubMed ID: 27444636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transition from oxcarbazepine to eslicarbazepine acetate: A single center study.
    Mäkinen J; Rainesalo S; Peltola J
    Brain Behav; 2017 Mar; 7(3):e00634. PubMed ID: 28293474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steady-state plasma and cerebrospinal fluid pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine in healthy volunteers.
    Nunes T; Rocha JF; Falcão A; Almeida L; Soares-da-Silva P
    Epilepsia; 2013 Jan; 54(1):108-16. PubMed ID: 22812691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.
    Zaccara G; Giovannelli F; Maratea D; Fadda V; Verrotti A
    Seizure; 2013 Sep; 22(7):528-36. PubMed ID: 23623245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EPICON consensus: recommendations for proper management of switching to eslicarbazepine acetate in epilepsy.
    Villanueva V; Ojeda J; Rocamora RA; Serrano-Castro PJ; Parra J; Rodríguez-Uranga JJ; Bathal H; Viteri C
    Neurologia (Engl Ed); 2018 Jun; 33(5):290-300. PubMed ID: 27349151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical guidance and considerations for transitioning patients from oxcarbazepine or carbamazepine to eslicarbazepine acetate--Expert opinion.
    Peltola J; Holtkamp M; Rocamora R; Ryvlin P; Sieradzan K; Villanueva V
    Epilepsy Behav; 2015 Sep; 50():46-9. PubMed ID: 26114438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine at steady state in healthy volunteers.
    Elger C; Bialer M; Falcão A; Vaz-da-Silva M; Nunes T; Almeida L; Soares-da-Silva P
    Epilepsia; 2013 Aug; 54(8):1453-61. PubMed ID: 23758485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eslicarbazepine acetate as adjunctive treatment in partial-onset epilepsy.
    Lattanzi S; Cagnetti C; Foschi N; Lorusso A; Provinciali L; Silvestrini M
    Acta Neurol Scand; 2018 Jan; 137(1):29-32. PubMed ID: 28741673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiepileptic drugs-induced hyponatremia: Review and analysis of 560 hospitalized patients.
    Intravooth T; Staack AM; Juerges K; Stockinger J; Steinhoff BJ
    Epilepsy Res; 2018 Jul; 143():7-10. PubMed ID: 29631131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term impact of the switch from immediate-release to extended-release oxcarbazepine in epilepsy patients on high dosages.
    Steinhoff BJ; Wendling AS
    Epilepsy Res; 2009 Dec; 87(2-3):256-9. PubMed ID: 19850448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of eslicarbazepine acetate at steady-state in adults with partial-onset seizures.
    Perucca E; Elger C; Halász P; Falcão A; Almeida L; Soares-da-Silva P
    Epilepsy Res; 2011 Sep; 96(1-2):132-9. PubMed ID: 21680153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-authorisation study of eslicarbazepine as treatment for drug-resistant epilepsy: preliminary results.
    Massot A; Vivanco R; Principe A; Roquer J; Rocamora R
    Neurologia; 2014 Mar; 29(2):94-101. PubMed ID: 23623701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Pharmacokinetic Interactions With Eslicarbazepine Acetate Versus Oxcarbazepine and Carbamazepine in Clinical Practice.
    Johannessen Landmark C; Svendsen T; Dinarevic J; Kufaas RF; Reimers A; Brodtkorb E; Baftiu A; Burns ML; Johannessen SI
    Ther Drug Monit; 2016 Aug; 38(4):499-505. PubMed ID: 27414974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term effects of dibenzazepines on metabolic parameters: retrospective comparison of carbamazepine, oxcarbazepine and eslicarbazepine acetate in the real world].
    Ley M; Principe A; Rocamora R
    Rev Neurol; 2020 Jul; 71(2):54-60. PubMed ID: 32627160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, tolerability and effectiveness of transition to eslicarbazepine acetate from carbamazepine or oxcarbazepine in clinical practice.
    Rocamora R; Peltola J; Assenza G; McMurray R; Villanueva V
    Seizure; 2020 Feb; 75():121-128. PubMed ID: 31981862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamazepine-, Oxcarbazepine-, Eslicarbazepine-Associated Movement Disorder: A Literature Review.
    Rissardo JP; Caprara ALF
    Clin Neuropharmacol; 2020; 43(3):66-80. PubMed ID: 32384309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A proposal for a model to replace carbamazepine or oxcarbazepine by eslicarbazepine acetate in clinical practice].
    Poza-Aldea JJ
    Rev Neurol; 2016 Sep; 63(5):219-23. PubMed ID: 27569568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study.
    Trinka E; Ben-Menachem E; Kowacs PA; Elger C; Keller B; Löffler K; Rocha JF; Soares-da-Silva P
    Epilepsia; 2018 Feb; 59(2):479-491. PubMed ID: 29369348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Slow release versus immediate release oxcarbazepine in difficult-to-treat focal epilepsy: a multicenter, randomized, open, controlled, parallel group phase III study].
    Steinhoff BJ; Stefan H; Schulze-Bonhage A; Hueber R; Paulus W; Wangemann M; Elger CE
    Nervenarzt; 2012 Oct; 83(10):1292-9. PubMed ID: 22850688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.